ENLIGHT-AML - An Open-label, Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT07084584 · WITHDRAWN
Trial details
- NCT number
- NCT07084584
- Sponsor
- Galecto Biotech AB
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-10
- Primary completion
- 2029-06-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.